Amarin Co. plc (NASDAQ: AMRN), Human Genome Sciences (NASDAQ: HGSI), Ingram Micro Inc. (NYSE: IM), Bed Bath & Beyond Inc. (NASDAQ: BBBY) and Chemed Corporation (NYSE: CHE) had ratings on them reiterated by analysts.
Canaccord Genuity reiterated its "Buy" rating on Amarin Co. plc (AMRN).
Brean Murray reiterated its "Hold" rating on Human Genome Sciences (HGSI).
Needham & Company reiterated its "Buy" rating on Ingram Micro Inc. (IM).
Nomura reiterated its "Neutral" rating on Bed Bath & Beyond Inc. (BBBY).
Oppenheimer reiterated its "Hold" rating on Chemed Corporation (CHE).
Thursday, November 17, 2011
Amarin (AMRN) (HGSI) (IM) (BBBY) (CHE) Ratings Reiterated
Labels:
Human Genome Sciences
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment